Pharmazon has received a minority investment from a private investor
The shareholders of Pharmazon have sold the company to a private investor.
Pharmazon is a B2B distributor of OTC and parapharmacy products to French pharmacies. Its core business is to buy products directly from laboratories, negotiating good conditions and selling them online through a modern website which looks similar to Amazon.com.
The company's shareholders are the CEO and General Director.
Oaklins' team in France advised the seller in this transaction.
Talk to the deal team
BlijWerkt has been acquired by Mentha Capital
Gilde Healthcare Partners has sold BlijWerkt Groep B.V. to Mentha Capital.Learn more
Lead Healthcare has successfully raised financing provided by Rabobank
Lead Healthcare has successfully raised financing provided by Rabobank.Learn more
ERBC (ex CERB) has acquired RTC
The European Research Biology Center (ERBC) has acquired the Research Toxicology Center (RTC).Learn more